By Karina Daiha Four recently published Guidelines shed light on ANVISA's procedures related to prior approval analysis of patent applications. In November 2020, the Brazilian Health…
VIPmarketingDecember 28, 2020
By Louis Lozouet The framework of innovation in Brazil The purpose of this article is to show that tax incentive policies fostering innovation and the…
VIPmarketingSeptember 22, 2020
By Karina Daiha (This article was first published on Mondaq on 4 June, and transcribes the interview conducted with Dr. Átila Duque Rossi, PhD, from…
VIPmarketingJune 4, 2020
By Karina Daiha and Julian Cornelius Since the arrival of the new Coronavirus in Brazil, the BRPTO has adopted several measures to assist in fighting…
VIPmarketingMay 26, 2020
By Andre Venturini Backlog is the first word that comes to an applicant’s mind when considering Brazil for patent filings. Indeed, at its worst, official…
VIPmarketingMay 18, 2020
By Julian Cornelius Over the last years, Brazil has significantly invested in its start-up industry. This can be seen in the creation of incubators, accelerators,…
VIPmarketingAugust 16, 2019
By Karina Daiha and Andre Venturini In a recent article, we analysed a study by the Brazilian Patent Office (INPI) on the categorization of biotechnology patent…
VIPmarketingMay 3, 2019
By Julian Cornelius On 12 February, by Rule235/2019, the INPI (the Brazilian Patent Office) initiated Phase II of the Patent Prosecution Highway (PPH) Pilot Project…
VIPmarketingFebruary 14, 2019
Irisin and the patentability of new methods for treating diseases in Brazil By Karina Daiha New research led by Brazilian scientists has indicated a relationship…
VIPmarketingJanuary 31, 2019